InvestorsHub Logo
Followers 23
Posts 2187
Boards Moderated 0
Alias Born 03/18/2013

Re: NewMoney post# 7417

Tuesday, 05/28/2013 9:01:26 PM

Tuesday, May 28, 2013 9:01:26 PM

Post# of 425923
Good grief! Insiders made good on every promise they've ever made and met every target they've ever set. If it wasn't for the fantastic move to Go it alone back in December, imagine where Amarin would be now. Now that AstraZeneca has shown it's hand and made the first (wrong) move. They were too weak in the knees to get into a bidding war with a "Best in Class" prescription drug like VASCEPA. Vascepa will turn the drug market on it's ear. Vascepa will not only take over the EPA market, they will eat into the Statin space as well. Then don't forget all the other ailments Vascepa will be prescribed for once they get Anchor approval and subsequently the off-label market. I really feel fortunate to own Amarin stock at this moment. Some who apparently sold their positions made out, but in the long run they would do much better if they bought Amarin at these levels and let it run.... as there is tremendous upside coming. The market will see that attempts to undermine Amarin is futile and will throw in the towel. Either your with us or against us, as my good buddy George Bush (GW) said.

GLTA,
Nuke
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News